Current concepts in the management of periocular infantile (capillary) hemangioma

Current Opinion in Ophthalmology

Volumn 22, Issue 5, 2011, Pages 419-425

  Ni, Nina ^a   Guo, Suqin ^b   Langer, Paul ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

Author keywords

blocker; capillary hemangioma; corticosteroids; infantile hemangioma; periorbital hemangioma; propranolol; timolol

Indexed keywords

ACEBUTOLOL; ALPHA2A INTERFERON; ANGIOTENSIN II; BASIC FIBROBLAST GROWTH FACTOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GELATINASE B; NITRIC OXIDE; PROPRANOLOL; TIMOLOL; VASCULOTROPIN A;

ADRENAL DISEASE; AGITATION; AMBLYOPIA; APOPTOSIS; ASTIGMATISM; BLEEDING; BRADYCARDIA; CAPILLARY HEMANGIOMA; CUSHINGOID SYNDROME; DRUG CHOICE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FAT ATROPHY; FATIGUE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERKALEMIA; HYPERTROPHIC CARDIOMYOPATHY; HYPOGLYCEMIA; HYPOPIGMENTATION; INDUCED HYPOTENSION; INFANT DISEASE; INTRAOCULAR PRESSURE; LETHARGY; LOW DRUG DOSE; PERIOCULAR INFANTILE HEMANGIOMA; PERSONALITY DISORDER; PRIORITY JOURNAL; PRURITUS; PULSED DYE LASER; RECOMMENDED DRUG DOSE; RETINA ARTERY OCCLUSION; REVIEW; SCAR FORMATION; SIDE EFFECT; SKIN ATROPHY; SLEEP DISORDER; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; WHEEZING; WOUND COMPLICATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; CHILD, PRESCHOOL; EYELID NEOPLASMS; FEMALE; HEMANGIOMA, CAPILLARY; HUMANS; INFANT; MALE; PROPRANOLOL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIMOLOL; TREATMENT OUTCOME;

EID: 80051800720     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0b013e32834994b4     Document Type: Review

References (82)

1. North PE, Waner M, Mizeracki A, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001;137:559-570. (Pubitemid 32458438)
2. Barnes CM, Huang S, Kaipainen A, et al. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci USA 2005;102:19097-19102. (Pubitemid 43049572)
3. North PE, Waner M, Mizeracki A, Mihm J M C. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Human Pathol 2000;31:11-22. (Pubitemid 30054381)
4. Yu Y, Flint AF, Mulliken JB, et al. Endothelial progenitor cells in infantile hemangioma. Blood 2004;103:1373-1375. (Pubitemid 38168651)
5. Boscolo E, Bischoff J. Vasculogenesis in infantile hemangioma. Angiogenesis 2009;12:197-207.
6. Wu JK, Adepoju O, De Silva D, et al. A switch in Notch gene expression parallels stem cell to endothelial transition in infantile hemangioma. Angiogenesis 2010;13:15-23.
7. Itinteang T, Tan ST, Brasch H, Day DJ. Primitive mesodermal cells with a neural crest stem cell phenotype predominate proliferating infantile haemangioma. J Clin Pathol 2010;63:771-776.
8. Peralta R, Glavas I. Review of capillary hemangioma. EyeNet 2009:35-37.
9. Schwartz SR, Blei F, Ceisler E, et al. Riskfactors for amblyopia in children with capillary hemangiomas of the eyelids and orbit. J AA PO S 2006;10:262-268. (Pubitemid 43928682)
10. Frank RC, Cowan BJ, Harrop AR, et al. Visual development in infants: visual complications of periocular haemangiomas. J Plast Reconstr Anesth Surg 2010;63:1-8.
11. Tambe K, Munshi V, Dewsbery C, et al. Relationship of infantile periocular hemangioma depth to growth and regression pattern. J AA PO S 2009;13:567-570.
12. Slaughter K, Sullivan T, Boulton J, et al. Early surgical intervention as definitive treatment for ocular adnexal capillary haemangioma. Clin Experiment Ophthalmol 2003;31:418-423. (Pubitemid 37461209)
13. Weiss AH, Kelly JP. Reappraisal of astigmatism induced by periocular capillary hemangioma and treatment with intralesional corticosteroid injection. Ophthalmology 2008;115:390.e391-397.e391.
14. Jalil A, Maino A, Bhojwani R, et al. Clinical review of periorbital capillary hemangioma of infancy. J Pediatr Ophthalmol Strabismus 2010;1-8.
15. Greenberger S, Boscolo E, Adini I, et al. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med 2010;362:1005-1013. Using a murine model, the authors show that inhibition of VEGF-A is a key target of corticosteroids in the treatment of infantile hemangioma.
16. Greenberger S, Adini I, Boscolo E, et al. Targeting NF-kappaB in infantile hemangioma-derived stem cells reduces VEGF-A expression. Angiogenesis 2010;13:327-335. The authors demonstrate that expression of several pro-angiogenic factors in hemangioma stem cells, including VEGF-A, is regulated by NF-B activity.
17. Cogen M, Elsas F. Eyelid depigmentation following corticosteroid injection for infantile ocular adnexal hemangioma. J Pediatr Ophthalmol Strabismus 1989;26:35-38. (Pubitemid 19027773)
18. Sutula FC, Glover AT. Eyelid necrosis following intralesional corticosteroid injection for capillary hemangioma. Ophthalmic Surg 1987;18:103-105. (Pubitemid 17032478)
19. Vazquez-Botet R, Reyes BA, Vazquez-Botet M. Sclerodermiform linear atrophy after the use of intralesional steroids for periorbital hemangiomas: a review of complications. J Pediatr Ophthalmol Strabismus 1989;26:124-127. (Pubitemid 19115836)
20. Droste P, Ellis F, Sondhi N, Helveston E. Linear subcutaneous fat atrophy after corticosteroid injection of periocular hemangiomas. Am J Ophthalmol 1988;105:65-69. (Pubitemid 18021345)
21. Shorr N, Seiff S. Central retinal artery occlusion associated with periocular corticosteroid injection for juvenile hemangioma. Ophthalmic Surg 1986;17:229-231. (Pubitemid 16117093)
22. Ruttum MS, Abrams GW, Harris GJ, Ellis MK. Bilateral retinal embolization associated with intralesional corticosteroid injection for capillary hemangioma of infancy. J Pediatr Ophthalmol Strabismus 1993;30:4-7. (Pubitemid 23101803)
23. Kushner B, Lemke B. Bilateral retinal embolization associated with intralesional corticosteroid injection for capillary hemangioma of infancy. J Pediatr Ophthalmol Strabismus 1993;30:397-399. (Pubitemid 24026843)
24. Stanbury RM, Graham EM. Systemic corticosteroid therapy: side effects and their management. Br J Ophthalmol 1998;82:704-708. (Pubitemid 28306665)
25. Boon LM, MacDonald DM, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 1999;104:1616-1623. (Pubitemid 29510480)
26. Kelly ME, Juern AM, Grossman WJ, et al. Immunosuppressive effects in infants treated with corticosteroids for infantile hemangiomas. Arch Dermatol 2010;146:767-774. The authors demonstrate significant reduction in lymphocyte count affecting immune function after oral corticosteroid administration for infantile hemangioma.
27. Frieden IJ. Commentary: early laser treatment of periorbital infantile hemangiomas may work, but is it really the best treatment option? Dermatol Surg 2010;36:598-601. The author reviews advantages and disadvantages of laser treatment for periorbital infantile hemangiomas.
28. Batta K, Goodyear H, Moss C, et al. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet 2002;360:521-527. (Pubitemid 35232105)
29. Stier MF, Glick SA, Hirsch RJ. Laser treatment of pediatric vascular lesions: port wine stains and hemangiomas. J Am Acad Dermatol 2008;58:261-285.
30. Hunzeker CM, Geronemus RG. Treatment of superficial infantile hemangiomas of the eyelid using the 595-nm pulsed dye laser. Dermatol Surg 2010;36:590-597.
31. Plager D, Snyder S. Resolution of astigmatism after surgical resection of capillary hemangioma in infants. Ophthalmology 1997;104:1102-1106. (Pubitemid 27423850)
32. Levi M, Schwartz S, Blei F, et al. Surgical treatment of capillary hemangiomas causing amblyopia. J AAPO S 2007;11:230-234. (Pubitemid 46899559)
33. Arneja JS, Mulliken JB. Resection of amblyogenic periocular hemangiomas: indications and outcomes. Plast Reconstr Surg 2010;125:274-281. In a review of 33 children with periocular hemangioma successfully managed by resection, the authors advocate early surgery to prevent amblyopia.
34. Walker R, Custer P, Nerad J. Surgical excision of periorbital capillary hemangiomas. Ophthal Plast Reconstr Surg 1996;12:73.
35. Wilson MW, Hoehn ME, Haik BG, et al. Low-dose cyclophosphamide and interferon alfa 2a for the treatment of capillary hemangioma of the orbit. Ophthalmology 2007;114:1007.e1001-1011.e1001.
36. Yu-Hua C, Der-Cherng L, Shu-Huey C, et al. Interferon-a for alarming hemangiomas in infants: experience of a single institution. Pediatr Int 2009;51:469-473.
37. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-2651. (Pubitemid 351831393)
38. Dunn AA, Zeidler K, Devcic Z, et al. Propranolol inhibits tubulogenesis in endothelioma cells and alters the expression of angiogenic genes in infantile hemangiomas. Plast Reconstr Surg 2010;125:1. Abstract confirming expression of b-2 adrenergic receptors on infantile hemangioma specimens and demonstrating possible mechanisms of action of b-blockade in the treatment of infantile hemangioma.
39. Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010;163:269-274. Excellent summary of possible mechanisms of action of propranolol for the treatment of infantile hemangiomas.
40. Dishy V, Sofowora GG, Xie H-G, et al. The effect of common polymorphisms of the {beta}2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001;345:1030-1035.
41. D'Angelo G, Lee H, Weiner R. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem 1997;67:353.
42. Iaccarino G, Ciccarelli M, Sorriento D, et al. Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res 2005;97:1182-1189.
43. Annabi B, Lachambre MP, Plouffe K, et al. Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion. Pharmacol Res 2009;60:438-445.
44. Sommers Smith S, Smith D. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim 2002;38:298-304. (Pubitemid 35204978)
45. Itinteang T, Brasch HD, Tan ST, Day DJ. Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution. J Plast Reconstr Aesthet Surg 2010. [Epub ahead of print] The authors present decreased activation of the renin-angiotensin-aldosterone system as a novel potential mechanism of action of propranolol in treating infantile hemangioma.
46. Sans V, de la Roque ED, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009;124:e423-431.
47. Muthamilselvan S, Vinoth PN, Vilvanathan V, et al. Hepatic haemangioma of infancy: role of propranolol. Ann Trop Paediatr 2010;30:335-338.
48. Sarialioglu F, Erbay A, Demir S. Response of infantile hepatic hemangioma to propranolol resistant to high-dose methylprednisolone and interferon-alpha therapy. Pediatr Blood Cancer 2010;55:1433-1434.
49. Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, et al. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pediatr 2010;157:340-342.
50. Manunza F, Syed S, Laguda B, et al. Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol 2010;162:466-468. Large case series outlining dermatologists' experience using propranolol to treat infantile hemangioma; three cases of isolated, asymptomatic hypotension were noted.
51. Bonifazi E, Acquafredda A, Milano A, et al. Severe hypoglycemia during successful treatment of diffuse hemangiomatosis with propranolol. Pediatr Dermatol 2010;27:195-196. Case report of hypoglycemia-induced seizures following use of propranolol for infantile hemangioma.
52. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009;26:610-614.
53. Holmes WJ, Mishra A, Gorst C, Liew SH. Propranolol as first-line treatment for infantile hemangiomas. Plast Reconstr Surg 2010;125:420-421.
54. Bigorre M, Van Kien AK, Valette H. Beta-blocking agent for treatment of infantile hemangioma. Plast Reconstr Surg 2009;123:195e-196e.
55. Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for infantile haemangioma. J Plast Reconstr Aesthet Surg 2011;64:292-299. The authors use 15 patients to determine the minimal dosage and duration of propranolol treatment to achieve accelerated involution of infantile hemangioma.
56. Truong MT, Chang KW, Berk DR, et al. Propranolol for the treatment of a lifethreatening subglottic and mediastinal infantile hemangioma. J Pediatr 2010;156:335-338.
57. Buckmiller LM. Update on hemangiomas and vascular malformations. Curr Opin Otolaryngol Head Neck Surg 2004;12:476-487. (Pubitemid 39565201)
58. Rosbe KW, Suh KY, Meyer AK, et al. Propranolol in the management of airway infantile hemangiomas. Arch Otolaryngol Head Neck Surg 2010;136:658-665.
59. Leboulanger N, Fayoux P, Teissier N, et al. Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: a preliminary retrospective study of French experience. Int J Pediatr Otorhinolaryngol 2010;74:1254-1257.
60. Denoyelle F, Leboulanger N, Enjolras O, et al. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 2009;73:1168-1172.
61. Jephson CG, Manunza F, Syed S, et al. Successful treatment of isolated subglottic haemangioma with propranolol alone. Int J Pediatr Otorhinolaryngol 2009;73:1821-1823.
62. Maturo S, Hartnick C. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int J Pediatr Otorhinolaryngol 2010;74:323-325.
63. Theletsane T, Redfern A, Raynham O, et al. Life-threatening infantile haemangioma: a dramatic response to propranolol. J Eur Acad Dermatol Venereol 2009;23:1465-1466.
64. Canadas KT, Baum ED, Lee S, Ostrower ST. Case report: treatment failure using propanolol for treatment of focal subglottic hemangioma. Int J Pediatr Otorhinolaryngol 2010;74:956-958. Study of propranolol treatment failure in a 2-month-old with subglottic infantile hemangioma.
65. Blanchet C, Nicollas R, Bigorre M, et al. Management of infantile subglottic hemangioma: acebutolol or propranolol? Int J Pediatr Otorhinolaryngol 2010;74:959-961.
66. Cheng JF, Gole GA, Sullivan TJ. Propranolol in management of periocular infantile haemangioma. Clin Experiment Ophthalmol 2010;38:7. Study of 10 children with periocular infantile hemangioma treated with propranolol; includes one case of treatment failure that required surgical resection.
67. Haider KM, Plager DA, Neely DE, et al. Outpatient treatment of periocular infantile hemangiomas with oral propranolol. J AAPOS 2010;14:251-256. Study of 17 children with periocular infantile hemangioma treated with propranolol.
68. Claerhout I, Buijsrogge M, Delbeke P, et al. The use of propranolol in the treatment of periocular infantile haemangiomas: a review. Br J Ophthalmol 2010. [Epub ahead of print] Excellent review of literature on the use of propranolol in the treatment of periocular infantile haemangioma, along with authors' unpublished series of 10 patients.
69. Al Dhaybi R, Superstein R, Milet A, et al. Treatment of periocular infantile hemangiomas with propranolol: case series of 18 children. Ophthalmology 2011;118:1184-1188. Largest case series of children with periocular infantile hemangioma treated with propranolol.
70. Guo S, Ni N, Wagner R, et al. Timolol as topical treatment for periocular hemangioma-induced astigmatism and anisometropic astigmatism. Presented at the Annual Meeting of the American Academy of Ophthalmology Annual Meeting, Chicago, IL, September, 2010; American Academy of Ophthalmology Annual Meeting Program, 2010;151. Initial study of reduction in periocular hemangioma-induced astigmatism and anisometropic astigmatism following treatment with topical timolol.
71. Taban M, Goldberg RA. Propranolol for orbital hemangioma. Ophthalmology 2010;117:195-195 e194.
72. Fay A, Nguyen J, Jakobiec FA, et al. Propranolol for isolated orbital infantile hemangioma. Arch Ophthalmol 2010;128:256-258.
73. Li YC, McCahon E, Rowe NA, et al. Successful treatment of infantile haemangiomas of the orbit with propranolol. Clin Experiment Ophthalmol 2010;38:554-559.
74. Pope E, Chakkittakandiyil A. Topical timolol gel for infantile hemangiomas: a pilot study. Arch Dermatol 2010;146:564-565.
75. Fabian ID, Ben-Zion I, Samuel C, Spierer A. Reduction in astigmatism using propranolol as first-line therapy for periocular capillary hemangioma. Am J Ophthalmol 2011;151:53-58. The authors show decrease in astigmatic error in three infants following use of propranolol as first-line treatment for periocular capillary hemangioma.
76. Holland KE, Frieden IJ, Frommelt PC, et al. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010;146:775-778. Study of three children who developed symptomatic hypoglycemia during treatment with propranolol for their infantile hemangioma.
77. Pavlakovic H, Kietz S, Lauerer P, et al. Hyperkalemia complicating propranolol treatment of an infantile hemangioma. Pediatrics 2010;126:e1589-e1593. Study of a 17-week-old infant who developed severe hyperkalemia during treatment with propranolol for infantile hemangioma.
78. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med 2008;359:2846; author reply 2846-2847.
79. Cushing SL, Boucek RJ, Manning SC, et al. Initial experience with a multidisciplinary strategy for initiation of propranolol therapy for infantile hemangiomas. Otolaryngol Head Neck Surg 2011;144:78-84.
80. Guo S, Ni N. Topical treatment for capillary hemangioma of the eyelid using {beta}-blocker solution. Arch Ophthalmol 2010;128:255-256. First study of topical p-blocker (timolol) used to treat periocular infantile hemangioma.
81. Ni N, Langer P, Wagner R, Guo S. Topical timolol for periocular hemangioma: report of further study. Arch Ophthalmol 2011;129:377-379. In a follow-up case series of seven children with periocular hemangioma treated with topical timolol, the authors report responses in all patients.
82. Khunger N, Pahwa M. Dramatic response of a large hemifacial infantile hemangioma associated with PHACE syndrome to topical timolol lotion. Br J Dermatol 2010;164:886-888. A study of dramatic response of a large, ulcerating hemifacial infantile hemangioma associated with PHACE syndrome to topical timolol.